Mersana Therapeutics Inc (MRSN) financials · rev $40.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Mersana Therapeutics Inc (MRSN) rev $40.5M.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $40.5M | $36.9M |
| Net Income | -$69.2M | -$171.7M |
| EPS (Diluted) | -$0.56 | -$1.48 |
| Line | FY2024 | FY2023 |
|---|---|---|
| Total Assets | $144.7M | $226.1M |
| Current Assets | $136.9M | $214.1M |
| Cash & Equivalents | $107.8M | $174.6M |
| PP&E | $2.20M | $3.83M |
| Total Liabilities | $154.2M | $189.2M |
| Current Liabilities | $62.5M | $63.6M |
| Short-term Debt | $12.5M | $2.08M |
| Long-term Debt | $10.9M | $23.1M |
| Total Debt | $23.4M† | $25.2M† |
| Shareholders' Equity | -$9.51M | $36.9M |
| Retained Earnings | -$895.6M | -$826.4M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$82.3M | -$168.9M |
| CapEx | $132.0K | $2.17M |
| Investing Cash Flow | $11.4M | $119.9M |
| Financing Cash Flow | $4.09M | $94.7M |
| Net Change in Cash | -$66.8M | $45.7M |
| Free Cash Flow | -$82.5M | -$171.1M |
FAQ
What is MRSN P/E and revenue?
Mersana Therapeutics Inc (MRSN) rev $40.5M.
What is MRSN revenue?
Mersana Therapeutics Inc last cached revenue is $40.5M (FY2024).
Is MRSN profitable?
Mersana Therapeutics Inc last cached net income is -$69.2M (FY2024).
What are MRSN total assets?
Mersana Therapeutics Inc last cached total assets are $144.7M (FY2024).
What is MRSN free cash flow?
Mersana Therapeutics Inc last cached free cash flow is -$82.5M (FY2024).
Not investment advice. Cached statements, not a live tape.